Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: Diagnostic implications

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 3, 2007, Pages 310-315

  Bakshi, Nasir ^a   Kunju, Lakshmi P ^b   Giordano, Thomas ^b   Shah, Rajal B ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Renal cell carcinoma antigen; Renal epithelial neoplasm

Indexed keywords

CANCER ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY RENAL CELL CARCINOMA; RENAL CELL CARCINOMA ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; KIDNEY TUMOR; LUNG CANCER; MELANOMA; OVARY CANCER; PARATHYROID CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; SCORING SYSTEM; TISSUE MICROARRAY;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; TISSUE ARRAY ANALYSIS;

EID: 34548266730     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000213144.70148.8e     Document Type: Article

References (12)

1. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-210.
2. Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Histopathology. 2004;45:452-459.
3. Gokden N, Mukunyadzi P, James JD, et al. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol. 2003;11:116-119.
4. Koga F, Kawano K, Honda M, et al. Sarcomatoid renal cell carcinoma with scant carcinomatous components. Int J Urol. 2000;7:58-60; discussion 61.
5. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am J Surg Pathol. 2001;25:1485-1492.
6. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol. 2001;158:1245-1251.
7. Rimm DL, Camp RL, Charette LA, et al. Tissue microarray: a new technology for amplification of tissue resources. Cancer J. 2001;7:24-31.
8. Javidan J, Stricker HJ, Tamboli P, et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol. 1999;162:1277-1281.
9. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001;25:275-284.
10. Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002;26:281-291.
11. Bui MH, Seligson D, Han KR, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res. 2003;9:802-811.
12. Fetsch PA, Powers CN, Zakowski MF, et al. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration. Cancer. 1999;87:168-172.